Zodef-24 Tablet

About Zodef-24 Tablet

Zodef-24 is a tablet made by Renata PLC. It contains the glucocorticoid deflazacort at a strength of 24 mg. It is a prescription medicine that a registered doctor decides when and how to use.

There are 28 brands of Deflazacort listed in Bangladesh. The lowest listed price is Dezert 6 mg Tablet at ৳ 8.00 per unit.

What is Zodef-24 Tablet?

Zodef-24 is a tablet manufactured by Renata PLC. Its active ingredient is deflazacort 24 mg, which belongs to a group of medicines called glucocorticoids. Deflazacort works by reducing inflammation and by lowering the release of certain natural chemicals involved in the immune system. It is a prescription medicine and is not meant for self-treatment. The dose, how often to take it, and how long to continue are all decided by the doctor, who will also consider other medicines the person is taking and any existing health problems.

Uses of Zodef-24

Deflazacort is used in a range of conditions linked to inflammation and immune activity. These include severe allergic reactions and asthma, several types of arthritis, and conditions such as systemic lupus erythematosus and dermatomyositis. It is also used in some skin conditions such as pemphigus. The doctor decides whether it suits a particular person and what the treatment plan should be.

How to use Zodef-24

Zodef-24 is a tablet that is swallowed. The doctor decides the dose, how often it is taken, and how long the course lasts, so follow the instructions given to you. Do not change the amount or stop suddenly on your own, because the doctor may need to adjust the medicine gradually. If you miss a dose or are unsure how to take it, ask your doctor or pharmacist. Read the label for storage and keep the tablets out of reach of children.

Side effects of Zodef-24

Like other glucocorticoids, deflazacort can cause unwanted effects. These may involve the stomach and bowel, muscles and bones, hormone-related changes, mood and sleep, the eyes, and fluid and salt balance. Some people become more prone to infection, and healing may be slower. Skin changes such as thinning, stretch marks and acne can occur. Tell your doctor if you notice any side effect, and seek medical help for anything severe.

Safety and precautions

Deflazacort crosses the placenta, and repeated or long use during pregnancy may carry risks, so it is only used when the doctor judges the benefit to mother and child to outweigh the risks. It passes into breast milk, so discuss breastfeeding with your doctor. Tell your doctor before starting if you have heart disease, high blood pressure, diabetes, stomach or bowel problems, or an infection, or if you have recently had a vaccination. Do not stop the medicine suddenly without medical advice; ask your doctor first.

Frequently asked questions

Is Zodef-24 safe to use during pregnancy or while breastfeeding?

Deflazacort crosses the placenta and passes into breast milk. It is used in pregnancy only when the doctor judges the benefits to outweigh the risks. If you are pregnant, planning a pregnancy or breastfeeding, tell your doctor before taking Zodef-24 so they can advise you.

What is Zodef-24 used for, and what kind of medicine is it?

Zodef-24 contains deflazacort, a glucocorticoid. It is used for conditions involving inflammation and immune activity, such as severe allergic reactions, asthma, some types of arthritis, and certain skin and connective tissue conditions. Your doctor will decide whether it is suitable for you.

What do the tablet form and 24 mg strength mean?

Zodef-24 comes as a tablet that is swallowed, and 24 mg tells you how much deflazacort each tablet contains. The strength does not tell you how much to take. Your doctor decides the dose, how often to take it, and how long the course lasts.

Can I stop taking Zodef-24 on my own?

No. Glucocorticoids such as deflazacort may need to be reduced gradually rather than stopped suddenly. Always follow your doctor's instructions about changing or ending treatment. If you have concerns or side effects, speak to your doctor or pharmacist before making any change.

Indications

Deflazacort is indicated in-
  • Anaphylaxis, asthma, severe hypersensitivity reactions
  • Rheumatoid arthritis, juvenile chronic arthritis, polymyalgia rheumatica
  • Systemic lupus erythematosus, dermatomyositis, mixed connective tissue disease (other than systemic sclerosis), polyartritis nodosa, sarcoidosis
  • ... Read more
Deflazacort is indicated in-
  • Anaphylaxis, asthma, severe hypersensitivity reactions
  • Rheumatoid arthritis, juvenile chronic arthritis, polymyalgia rheumatica
  • Systemic lupus erythematosus, dermatomyositis, mixed connective tissue disease (other than systemic sclerosis), polyartritis nodosa, sarcoidosis
  • Pemphigus,bullous pemphigoid, pyoderma gangrenosum
  • Minimal change nephrotic syndrome, acute interstitial nephritis
  • Rheumatic carditis
  • Ulcerative colitis, Crohn's disease
  • Uveitis, optic neuritis
  • Autoimmune haemolytic anaemia, idiopathic thrombocytopenic purpura
  • Acute and lymphatic leukaemia, malignant lymphoma, multiple myeloma
  • Immune suppression in transplantation

Pharmacology

Deflazacort provides anti-inflammatory action by inhibiting Phospholipase A2 enzyme which is responsible for prostaglandin synthesis. Besides Deflazacort decreases the release of certain chemicals that are important in the immune system. By decreasing the release of these chemicals Deflazacort provides immunosuppressive action.

Dosage & Administration

Adults-
  • For acute disorders: Up to 120 mg/day Deflazacort may need to be given initially. Maintenance doses in most conditions are within the range of 3-18 mg/day.
  • Rheumatoid arthritis: The maintenance dose is usually within the range of 3-18 mg/day. The smallest effective dose should be used and increased if necessary.
  • Bronchial asthma: In the treatment of an acute attack, high doses of 48-72 mg/day may be needed depending on severity and gradually reduced once the attack has been controlled. For maintenance in chronic asthma, doses should be titrated to the lowest dose that controls symptoms.
  • Other conditions: The dose of Deflazacort depends on clinical need titrated to the lowest effective dose for maintenance. Starting doses may be estimated on the basis of ratio of 5 mg prednisone or prednisolone to 6 mg.
Children: There has been limited exposure of children to Deflazacort in clinical trials. In children, the indications for glucocorticoids arethe same as for adults, but it is important that the lowest effective dosage is used. Alternate day administration may be appropriate. Doses of Deflazacort usually lie in the range 0.25-1.5 mg/kg/day.

The following ranges provide general guidance:
  • Juvenile chronic arthritis: The usual maintenance dose is between 0.25-1.0 mg/kg/day.
  • Nephrotic syndrome: Initial dose of usually 1.5 mg/kg/day followed by down titration according to clinical need.
  • Bronchial asthma: On the basis of the potency ratio, the initial dose should be between 0.25-1.0 mg/kg on alternate days.
Deflazacort withdrawal: In patients who have received more than physiological doses of systemic corticosteroids (approximately 9 mg per day or equivalent) for greater than 3 weeks, withdrawal should not be abrupt. How dose reduction should be carried out depends largely on whether the disease is likely to relapse as the dose of systemic corticosteroids is reduced.

Interaction

Deflazacort is metabolized in the liver. It is recommended to increase the maintenance dose of Deflazacort if drugs which are liver enzyme inducers are co-administered, e.g. rifampicin, rifabutin, carbamazepine, phenobarbitone, phenytoin, primidone and aminoglutethimide. For drugs which inhibit liver enzymes, (e.g. ketoconazole) it may be possible to reduce the maintenance dose of Deflazacort.

Contraindications

Hypersensitivity to or any of the ingredients. Patients receiving live virus immunization.

Side Effects

GI disturbances, musculoskeletal, endocrine, neuropsychiatric, ophthalmic, fluid and electrolyte disturbances; susceptible to infection, impaired healing, hypersensitivity, skin atrophy, striae, telangiectasia, acne, myocardial rupture following recent Ml, thromboembolism.

Pregnancy & Lactation

Pregnancy: Deflazacort does cross the placenta. However, when administered for prolonged periods or repeatedly during pregnancy, corticosteroids may increase the risk of intrauterine growth retardation. As with all drugs, corticosteroids should only be prescribed when the benefits to the mother and child outweigh the risks.

Nursing Mother: Corticosteroids are excreted in breast milk, although no data are available for Deflazacort. Doses of up to 50 mg daily of Deflazacort are unlikely to cause systemic effects in the infant. Infants of mothers taking higher doses than this may have a degree of adrenal suppression but the benefits of breastfeeding are likely to outweigh any theoretical risk.

Precautions & Warnings

The following clinical conditions require special caution and frequent patient monitoring is necessary-
  • Cardiac disease or congestive heart failure (except in the presence of active rheumatic carditis), hypertension, thromboembolic disorders. Glucocorticoids can cause salt and water retention and increased excretion of potassium. Dietary salt restriction and potassium supplementation may be necessary.
  • Gastritis or oesophagitis, diverticulitis, ulcerative colitis if there is the probability of impending perforation, abscess or pyogenic infections, fresh intestinal anastomosis, active or latent peptic ulcer.
  • Diabetes mellitus or family history, osteoporosis, myasthenia gravis, renal insufficiency.
  • Emotional instability or psychotic tendency, epilepsy.
  • Previous corticosteroid-induced myopathy.
  • Liver failure.
  • Hypothyroidism and cirrhosis, which may increase the glucocorticoid effect.
  • Ocular herpes simplex because of possible corneal perforation.

Storage Conditions

Store in a cool (below 25°C) and dry place, protected from light & moisture. Keep out of the reach of children.

Alternative brands of Deflazacort

Other brands with the same generic name, cheapest first.

See all 28 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.